Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study of Diagnosis, Treatment and Prognosis of Malignant Pleural Mesothelioma in China

NCT05042557 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT05042557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05042557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study of Diagnosis, Treatment and Prognosis of Malignant Pleural Mesothelioma in China
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
December 20, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnoses disease, malignant pleural mesothelioma, prognosis, treatments